The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Opioids for neuropathic pain
Open accessAbstract
BACKGROUND: This is an updated version of the original Cochrane review published in Issue 3, 2006, which included 23 trials. The use of opioids for neuropathic pain remains controversial. Studies have been small, have yielded equivocal results, and have not established the long-term profile of benefits and risks for people with neuropathic pain. OBJECTIVES: To reassess the efficacy and safety of opioid agonists for the treatment of neuropathic pain. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (to 24th October 2012), MEDLINE (1966 to 24th October 2012 ), and EMBASE (1980 to 24th October 2012) for articles in any language, and reference lists of reviews and retrieved articles. SELECTION CRITERIA: We included randomized controlled trials (RCTs) in which opioid agonists were given to treat central or peripheral neuropathic pain of any etiology. Pain was assessed using validated instruments, and adverse events were reported. We excluded studies in which drugs other than opioid agonists were combined with opioids or opioids were administered epidurally or intrathecally. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and included demographic variables, diagnoses, interventions, efficacy, and adverse effects. MAIN RESULTS: Thirty-one trials met our inclusion criteria, studying 10 different opioids: 23 studies from the original 2006 review and eight additional studies from this updated review.Seventeen studies (392 participants with neuropathic pain, average 22 participants per study) provided efficacy data for acute exposure to opioids over less than 24 hours. Sixteen reported pain outcomes, with contradictory results; 8/16 reported less pain with opioids than placebo, 2/16 reported that some but not all participants benefited, 5/16 reported no difference, and 1/16 reported equivocal results. Six studies with about 170 participants indicated that mean pain scores with opioid were about 15/100 points less than placebo.Fourteen studies (845 participants, average 60 participants per study) were of intermediate duration lasting 12 weeks or less; most studies lasted less than six weeks. Most studies used imputation methods for participant withdrawal known to be associated with considerable bias; none used a method known not to be associated with bias. The evidence, therefore, derives from studies predominantly with features likely to overestimate treatment effects, i.e. small size, short duration, and potentially inadequate handling of dropouts. All demonstrated opioid efficacy for spontaneous neuropathic pain. Meta-analysis demonstrated at least 33% pain relief in 57% of participants receiving an opioid versus 34% of those receiving placebo. The overall point estimate of risk difference was 0.25 (95% confidence interval (CI) 0.13 to 0.37, P < 0.0001), translating to a number needed to treat for an additional beneficial outcome (NNTB) of 4.0 (95% CI 2.7 to 7.7). When the number of participants achieving at least 50% pain relief was analyzed, the overall point estimate of risk difference between opioids (47%) and placebo (30%) was 0.17 (95% CI 0.02 to 0.33, P = 0.03), translating to an NNTB of 5.9 (3.0 to 50.0). In the updated review, opioids did not demonstrate improvement in many aspects of emotional or physical functioning, as measured by various validated questionnaires. Constipation was the most common adverse event (34% opioid versus 9% placebo: number needed to treat for an additional harmful outcome (NNTH) 4.0; 95% CI 3.0 to 5.6), followed by drowsiness (29% opioid versus 14% placebo: NNTH 7.1; 95% CI 4.0 to 33.3), nausea (27% opioid versus 9% placebo: NNTH 6.3; 95% CI 4.0 to 12.5), dizziness (22% opioid versus 8% placebo: NNTH 7.1; 95% CI 5.6 to 10.0), and vomiting (12% opioid versus 4% placebo: NNTH 12.5; 95% CI 6.7 to 100.0). More participants withdrew from opioid treatment due to adverse events (13%) than from placebo (4%) (NNTH 12.5; 95% CI 8.3 to 25.0). Conversely, more participants receiving placebo withdrew due to lack of efficacy (12%) versus (2%) receiving opioids (NNTH -11.1; 95% CI -20.0 to -8.3). AUTHORS' CONCLUSIONS: Since the last version of this review, new studies were found providing additional information. Data were reanalyzed but the results did not alter any of our previously published conclusions. Short-term studies provide only equivocal evidence regarding the efficacy of opioids in reducing the intensity of neuropathic pain. Intermediate-term studies demonstrated significant efficacy of opioids over placebo, but these results are likely to be subject to significant bias because of small size, short duration, and potentially inadequate handling of dropouts. Analgesic efficacy of opioids in chronic neuropathic pain is subject to considerable uncertainty. Reported adverse events of opioids were common but not life-threatening. Further randomized controlled trials are needed to establish unbiased estimates of long-term
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,178
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Chapter 9: Analysing Data and Undertaking Meta-Analyses
Deeks, J. J., Higgins, J. P. T., & Altman, D. G. (2008) · Cited by 2,782
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Baron, R., Binder, A., & Wasner, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70143-5 · Cited by 1,816
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,325
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,144
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Weaver, D. F., & Houlden, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042580 · Cited by 1,091
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Maier, C., Baron, R., Tölle, T. R., Binder, A., Birbaumer, N., Birklein, F., Gierthmühlen, J., Flor, H., Geber, C., Huge, V., et al. (2010) · Pain · doi:10.1016/j.pain.2010.05.002 · Cited by 1,021
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
Arnér, S., & Meyerson, B. A. (1988) · Pain · doi:10.1016/0304-3959(88)90198-4 · Cited by 991
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 959
Pergolizzi, J., Böger, R. H., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H., Langford, R., Likar, R., Raffa, R. B., et al. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00204.x · Cited by 854
Treatment of neuropathic pain: an overview of recent guidelines.
O'Connor, A. B., & Dworkin, R. H. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.04.007 · Cited by 781
Chapter 16: Special Topics in Statistics
Higgins, J. P. T., Deeks, J. J., & Altman, D. (2008) · Cited by 728
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Efficacy of oxycodone in neuronathic pain: A randomized trial in postherpetic neuralgia
N. Watson, C. P., & Babul, N. (1998) · Neurology · doi:10.1212/wnl.50.6.1837 · Cited by 646
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s63 · Cited by 642
Opioid Dose and Drug-Related Mortality in Patients With Nonmalignant Pain
Gomes, T., Mamdani, M. M., Dhalla, I. A., Paterson, J. M., & Juurlink, D. N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.117 · Cited by 638
Moore, A. R., Gavaghan, D., Tramèr, R. M., Collins, L. S., & McQuay, J. H. (1998) · Pain · doi:10.1016/s0304-3959(98)00140-7 · Cited by 604
Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial
Raja, S. N., Haythornthwaite, J. A., Pappagallo, M., Clark, M. R., Travison, T. G., Sabeen, S., Royall, R. M., & Max, M. B. (2002) · Neurology · doi:10.1212/wnl.59.7.1015 · Cited by 593
The impact of neuropathic pain on health-related quality of life: Review and implications
Jensen, M. P., Chodroff, M. J., & Dworkin, R. H. (2007) · Neurology · doi:10.1212/01.wnl.0000259085.61898.9e · Cited by 575
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Tschannen, B., Altman, D. G., Egger, M., & Juni, P. (2010) · BMJ · doi:10.1136/bmj.c3515 · Cited by 559
Moulin, D., Clark, A., Gilron, I., Ware, M., Watson, C., Sessle, B., Coderre, T., Morley-Forster, P., Stinson, J., Boulanger, A., et al. (2007) · Pain Research and Management · doi:10.1155/2007/730785 · Cited by 557
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
Rowbotham, M. C., Twilling, L., Davies, P. S., Reisner, L., Taylor, K., & Mohr, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021420 · Cited by 529
Watson, P. C. N., Moulin, D., Watt-Watson, J., Gordon, A., & Eisenhoffer, J. (2003) · Pain · doi:10.1016/s0304-3959(03)00160-x · Cited by 510
Eide, P. K., Jørum, E., Stubhaug, A., Bremnes, J., & Breivik, H. (1994) · Pain · doi:10.1016/0304-3959(94)90129-5 · Cited by 490
Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia
Rowbotham, M. C., Reisner-Keller, L. A., & Fields, H. L. (1991) · Neurology · doi:10.1212/wnl.41.7.1024 · Cited by 477
Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial
Gimbel, J. S., Richards, P., & Portenoy, R. K. (2003) · Neurology · doi:10.1212/01.wnl.0000057720.36503.2c · Cited by 469
Eisenberg, E., McNicol, E. D., & Carr, D. B. (2005) · JAMA · doi:10.1001/jama.293.24.3043 · Cited by 407
Self-citationOpioid Therapy and Immunosuppression: A Review
Vallejo, R., de Leon-Casasola, O., & Benyamin, R. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000132250.95650.85 · Cited by 386
“Evidence” in chronic pain–establishing best practice in the reporting of systematic reviews
Moore, A. R., Eccleston, C., Derry, S., Wiffen, P., Bell, R. F., Straube, S., & McQuay, H. (2010) · Pain · doi:10.1016/j.pain.2010.05.011 · Cited by 370
Sehgal, N. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es67 · Cited by 326
The effect of opioids on phantom limb pain and cortical reorganization
Huse, E., Larbig, W., Flor, H., & Birbaumer, N. (2001) · Pain · doi:10.1016/s0304-3959(00)00385-7 · Cited by 309
Moore, R. A., Moore, O. A., Derry, S., Peloso, P. M., Gammaitoni, A. R., & Wang, H. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.107805 · Cited by 279
Duehmke, R. M., Hollingshead, J., & Cornblath, D. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003726.pub3 · Cited by 267
Buynak, R., Shapiro, D. Y., Okamoto, A., Hove, I. V., Rauschkolb, C., Steup, A., Lange, B., Lange, C., & Etropolski, M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.497720 · Cited by 252
Max, M. B., Schafer, S. C., Culnane, M., Dubner, R., & Gracely, R. H. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.44 · Cited by 247
Peripheral neuropathic pain—a multidimensional burden for patients
Meyer‐Rosberg, K., Kvarnström, A., Kinnman, E., Gordh, T., Nordfors, L., & Kristofferson, A. (2001) · European Journal of Pain · doi:10.1053/eujp.2001.0259 · Cited by 247
Eide, P. K., Stubhaug, A., & Stenehjem, A. E. (1995) · Neurosurgery · doi:10.1227/00006123-199512000-00007 · Cited by 235
Hanna, M., O'Brien, C., & Wilson, M. C. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2007.12.010 · Cited by 225
Are opioids effective in relieving neuropathic pain?
Dellemijn, P. (1999) · Pain · doi:10.1016/s0304-3959(98)00256-5 · Cited by 225
Effects of IV morphine in central pain: A randomized placebo-controlled study
Attal, N., Guirimand, F., Brasseur, L., Gaude, V., Chauvin, M., & Bouhassira, D. (2002) · Neurology · doi:10.1212/wnl.58.4.554 · Cited by 224
Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain
Khoromi, S., Cui, L., Nackers, L., & Max, M. B. (2007) · Pain · doi:10.1016/j.pain.2006.10.029 · Cited by 216
Frank, B., Serpell, M. G., Hughes, J., Matthews, J. N. S., & Kapur, D. (2008) · BMJ · doi:10.1136/bmj.39429.619653.80 · Cited by 207
Kupers, R. C., Konings, H., Adriaensen, H., & Gybels, J. M. (1991) · Pain · doi:10.1016/0304-3959(91)90004-h · Cited by 206
Dellemijn, P. L., & Vanneste, J. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09024-1 · Cited by 204
Jadad, A. R., Carroll, D., Glynn, C. J., McQuay, H. J., & Moore, R. A. (1992) · The Lancet · doi:10.1016/0140-6736(92)91194-d · Cited by 200
Wu, C. L., Tella, P., Staats, P. S., Vaslav, R., Kazim, D. A., Wesselmann, U., & Raja, S. N. (2002) · Anesthesiology · doi:10.1097/00000542-200204000-00010 · Cited by 197
Jørum, E., Warncke, T., & Stubhaug, A. (2003) · Pain · doi:10.1016/s0304-3959(02)00122-7 · Cited by 196
Harke, H., Gretenkort, P., Ladleif, H. U., Rahman, S., & Harke, O. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200102000-00039 · Cited by 189
Sittl, R. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90019-1 · Cited by 186
Moore, A. R., Straube, S., Eccleston, C., Derry, S., Aldington, D., Wiffen, P., Bell, R. F., Hamunen, K., Phillips, C., & McQuay, H. (2012) · Pain · doi:10.1016/j.pain.2011.10.004 · Cited by 179
Max, M. B., Byas-Smith, M. G., Gracely, R. H., & Bennett, G. J. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199508000-00008 · Cited by 170
Arkinstall, W., Sandler, A., Goughnour, B., Babul, N., Harsanyi, Z., & Darke, A. C. (1995) · Pain · doi:10.1016/0304-3959(94)00262-d · Cited by 164
Dunbar, S. A., & Katz, N. P. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00165-4 · Cited by 163
Leung, A., Wallace, M. S., Ridgeway, B., & Yaksh, T. (2001) · Pain · doi:10.1016/s0304-3959(00)00433-4 · Cited by 159
Morley, J. S., Bridson, J. D., Nash, T. P., Miles, J. B., White, S. J., & Makin, M. K. (2003) · Palliative Medicine · doi:10.1191/0269216303pm815oa · Cited by 157
Maier, C., Hildebrandt, J., Klinger, R., Henrich-Eberl, C., & Lindena, G. (2002) · Pain · doi:10.1016/s0304-3959(02)00020-9 · Cited by 156
Rabben, T., Skjelbred, P., & Øye, I. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38236-9 · Cited by 149
Rhodin, A., Stridsberg, M., & Gordh, T. (2010) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181d1059d · Cited by 142
Eisenberg, E., McNicol, E. D., & Carr, D. B. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006146 · Cited by 138
Self-citationDose-response relationship of opioids in nociceptive and neuropathic postoperative pain
Benedetti, F., Vighetti, S., Amanzio, M., Casadio, C., OLIARO, A., Bergamasco, B., & Maggi, G. (1998) · Pain · doi:10.1016/s0304-3959(97)00172-3 · Cited by 133
Morphine versus Mexiletine for Treatment of Postamputation Pain
Wu, C. L., Agarwal, S., Tella, P. K., Klick, B., Clark, M. R., Haythornthwaite, J. A., Max, M. B., & Raja, S. N. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31817f4523 · Cited by 123
Sorge, J., & Sittl, R. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.11.008 · Cited by 121
Opioid-Induced Hyperalgesia: Clinically Relevant or Extraneous Research Phenomenon?
Tompkins, D. A., & Campbell, C. M. (2011) · Current Pain and Headache Reports · doi:10.1007/s11916-010-0171-1 · Cited by 117
Offset Analgesia in Neuropathic Pain Patients and Effect of Treatment with Morphine and Ketamine
Niesters, M., Hoitsma, E., Sarton, E. Y., Aarts, L. P. H. J., & Dahan, A. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31822fd03a · Cited by 104
Gatti, A., Sabato, A. F., Occhioni, R., Baldeschi, G. C., & Reale, C. A. (2008) · European Neurology · doi:10.1159/000186502 · Cited by 100
Simpson, D. M., Messina, J. C., Xie, F., & Hale, M. E. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.04.007 · Cited by 98
Zin, C. S., Nissen, L. M., O'Callaghan, J. P., Duffull, S. B., Smith, M. T., & Moore, B. J. (2009) · Journal of Pain · doi:10.1016/j.jpain.2009.09.003 · Cited by 97
Opioid sensitivity of chronic pain: a patient‐controlled analgesia method
McQuay, H. J., Jadad, A. R., Carroll, D., Faura, C. C., Glynn, C. J., Moore, R. A., & LIU, Y. (1992) · Anaesthesia · doi:10.1111/j.1365-2044.1992.tb03253.x · Cited by 92
Dworkin, R. H., Barbano, R. L., Tyring, S. K., Betts, R. F., McDermott, M., Pennella‐Vaughan, J., Bennett, G. J., Berber, E., Gnann, J. W., Irvine, C., et al. (2009) · Pain · doi:10.1016/j.pain.2008.12.022 · Cited by 92
Jensen, M. P., Friedman, M., Bonzo, D., & Richards, P. T. (2005) · Clinical Journal of Pain · doi:10.1097/01.ajp.0000173018.64741.62 · Cited by 86
Kaiman, S., Österberg, A., Sörensen, J., et al. (2002) · European Journal of Pain · doi:10.1053/eujp.2001.0307 · Cited by 70
MorphiDex® (MS:DM) Double-Blind, Multiple-Dose Studies In Chronic Pain Patients
Katz, N. P. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00129-3 · Cited by 68
Sullivan, M. D., & FERRELL, B. R. (2004) · Journal of Pain · doi:10.1016/j.jpain.2004.10.006 · Cited by 64
Buprenorphine in a Transdermal Therapeutic System – A New Option
̈hme, K. B. (2002) · Clinical Rheumatology · doi:10.1007/s100670200031 · Cited by 59
McQuay, H. J. (1997) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1997.tb04634.x · Cited by 53
Palangio, M., Damask, M., Morris, E., Doyle, R. T., Jiang, J. G., Landau, C., & de Padova, A. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80060-0 · Cited by 49
Kalso, E., Simpson, K., Slappendel, R., Dejonckheere, J., & Richarz, U. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-39 · Cited by 47
Nicholson, B., Ross, E., Sasaki, J., & Weil, A. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x115603 · Cited by 44
Analgesic effects of dextromethorphan and morphine in patients with chronic pain
Heiskanen, T., Härtel, B., Dahl, M., Seppälä, T., & Kalso, E. A. (2002) · Pain · doi:10.1016/s0304-3959(01)00455-9 · Cited by 42
McCleane, G. J. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01388-5 · Cited by 38
Transdermales Buprenorphin fur die Behandlung chronischer Tumor- und Nicht-Tumorschmerzen
Likar, R., Grießinger, N., Sadjak, A., & Sittl, R. (2003) · Wiener Medizinische Wochenschrift · doi:10.1046/j.1563-258x.2003.02120.x · Cited by 25
Nicholson, B. D., Ross, E. L., Weil, A. J., Sasaki, J., & Sacks, G. M. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x89784 · Cited by 24
Pain Management: Evidence, Outcomes, and Quality of Life: A Sourcebook.
Gilligan, C. J., Rathmell, J. P., & Warner, M. A. A. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181a96ffd · Cited by 20
Multidose/Observational, Comparative Clinical Analgetic Evaluation of Buprenorphine
Mok, M. S., Lippmann, M., & Steen, S. N. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb01774.x · Cited by 16
Yao, P., Meng, L.-X., Ma, J., Ding, Y.-Y., Wang, Z., Zhao, G., Tao, R., Wu, Y., Wang, Q., Zhang, Z., et al. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01274.x · Cited by 10
Intravenous opioid testing in patients with chronic non‐cancer pain
Gustorff, B. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.05.006 · Cited by 9
The tract of Lissauer and the dorsal root potential
Cervero, F., Iggo, A., & Molony, V. (1979) · Pain · doi:10.1016/0304-3959(79)90013-7 · Cited by 7
Cruciani, R. A., Katz, N. P., & Portenoy, R. K. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.01.007 · Cited by 6
Cited by
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Pharmacological Management of Persistent Pain in Older Persons
(2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00699.x · Cited by 916
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 910
Pergolizzi, J., Böger, R. H., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H., Langford, R., Likar, R., Raffa, R. B., et al. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00204.x · Cited by 854
Metadata
- Authors
- McNicol, E. D., Midbari, A., & Eisenberg, E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-08-29
- Volume
- 2019
- Issue
- 1
- Pages
- CD006146-CD006146
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1546041226
- Cited by
- 434
- References
- 101
- FWCI
- 50.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.